From the Department of Cardiovascular Medicine (F.F., K.M.P., K.Q., D.D., M.O., M.P., M.G.R.-P.), Mayo Clinic, Rochester, MN.
Department of Radiology (T.L.K.), Mayo Clinic, Rochester, MN.
Hypertension. 2020 Dec;76(6):1889-1897. doi: 10.1161/HYPERTENSIONAHA.120.15483. Epub 2020 Oct 5.
Polycystic kidney disease (PKD) has been linked to abnormal structure/function of ciliary proteins, leading to renal dysfunction. Recently, attention has been focused in the significant vascular abnormalities associated with PKD, but the mechanisms underlying this phenomenon remain elusive. Here, we seek to define the molecular events regulating the angiogenic imbalance observed in PKD. Using micro computed tomography (n=7) and protein expression analysis (n=5), we assessed the vascular density and the angiogenic profile of noncystic organs in a well-established PKD rat model (Polycystic Kidney-PCK rat). Heart and lungs of PCK rats have reduced vascular density and decreased expression of angiogenic factors compared with wild type. Similarly, PCK-vascular smooth muscle cells (VSMCs; n=4) exhibited lower levels of vascular markers. Then, using small interfering RNA (n=4), we determined the role of the ciliary protein fibrocystin in wild type-VSMCs, a critical component/regulator of vascular structure and function. Reduction of fibrocystin in wild type-VSMCs (n=4) led to an abnormal angiogenic potential similar to that observed in PCK-VSMCs. Furthermore, we investigated the involvement of the hedgehog signaling, a pathway closely linked to the primary cilium and associated with vascular development, in PKD. Mechanistically, we demonstrated that impairment of the hedgehog signaling mediates, in part, this abnormal angiogenic phenotype. Lastly, overexpression of Gli1 in PCK-VSMCs (n=4) restored the expression levels of proangiogenic molecules. Our data support a critical role of fibrocystin in the abnormal vascular phenotype of PKD and indicate that a dysregulation of hedgehog may be responsible, at least in part, for these vascular deficiencies.
多囊肾病 (PKD) 与纤毛蛋白的结构/功能异常有关,导致肾功能障碍。最近,人们关注与 PKD 相关的显著血管异常,但这种现象的机制仍不清楚。在这里,我们试图确定调节 PKD 中观察到的血管生成失衡的分子事件。使用微计算机断层扫描(n=7)和蛋白质表达分析(n=5),我们评估了在既定的 PKD 大鼠模型(多囊肾-PCK 大鼠)中非囊组织的血管密度和血管生成谱。与野生型相比,PCK 大鼠的心脏和肺的血管密度降低,血管生成因子的表达减少。同样,PCK-血管平滑肌细胞(VSMCs;n=4)表现出较低的血管标志物水平。然后,我们使用小干扰 RNA(n=4),确定纤毛蛋白多囊蛋白在野生型-VSMCs 中的作用,这是血管结构和功能的关键组成部分/调节剂。野生型-VSMCs 中多囊蛋白的减少(n=4)导致类似观察到的 PCK-VSMCs 的异常血管生成潜能。此外,我们研究了 hedgehog 信号通路的参与,该通路与初级纤毛密切相关,并与血管发育有关,在 PKD 中。从机制上讲,我们证明 hedgehog 信号通路的损伤部分介导了这种异常的血管生成表型。最后,Gli1 在 PCK-VSMCs 中的过表达(n=4)恢复了促血管生成分子的表达水平。我们的数据支持纤毛蛋白在 PKD 异常血管表型中的关键作用,并表明 hedgehog 的失调至少部分负责这些血管缺陷。